284 related articles for article (PubMed ID: 33682583)
1.
de la Maza LM; Darville TL; Pal S
Expert Rev Vaccines; 2021 Apr; 20(4):421-435. PubMed ID: 33682583
[TBL] [Abstract][Full Text] [Related]
2. Update on Chlamydia trachomatis Vaccinology.
de la Maza LM; Zhong G; Brunham RC
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28228394
[TBL] [Abstract][Full Text] [Related]
3. Towards a Chlamydia trachomatis vaccine: how close are we?
Cochrane M; Armitage CW; O'Meara CP; Beagley KW
Future Microbiol; 2010 Dec; 5(12):1833-56. PubMed ID: 21155665
[TBL] [Abstract][Full Text] [Related]
4.
Borges ÁH; Follmann F; Dietrich J
Expert Rev Vaccines; 2022 Nov; 21(11):1555-1567. PubMed ID: 36004386
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.
Pal S; Favaroni A; Tifrea DF; Hanisch PT; Luczak SET; Hegemann JH; de la Maza LM
Vaccine; 2017 May; 35(19):2543-2549. PubMed ID: 28385608
[TBL] [Abstract][Full Text] [Related]
6. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
Igietseme JU; Murdin A
Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.
Coler RN; Bhatia A; Maisonneuve JF; Probst P; Barth B; Ovendale P; Fang H; Alderson M; Lobet Y; Cohen J; Mettens P; Reed SG
FEMS Immunol Med Microbiol; 2009 Mar; 55(2):258-70. PubMed ID: 19281568
[TBL] [Abstract][Full Text] [Related]
8. Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects.
Hafner LM; Timms P
Expert Rev Vaccines; 2018 Jan; 17(1):57-69. PubMed ID: 29264970
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.
Yu H; Karunakaran KP; Jiang X; Shen C; Andersen P; Brunham RC
Infect Immun; 2012 Apr; 80(4):1510-8. PubMed ID: 22290151
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Chlamydia trachomatis genital challenge pig model for testing recombinant protein vaccines.
Schautteet K; Stuyven E; Cox E; Vanrompay D
J Med Microbiol; 2011 Jan; 60(Pt 1):117-127. PubMed ID: 20847123
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
Tifrea DF; Ralli-Jain P; Pal S; de la Maza LM
Infect Immun; 2013 May; 81(5):1741-50. PubMed ID: 23478318
[TBL] [Abstract][Full Text] [Related]
12. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
[TBL] [Abstract][Full Text] [Related]
13. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.
Brunham RC; Rey-Ladino J
Nat Rev Immunol; 2005 Feb; 5(2):149-61. PubMed ID: 15688042
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to Variable Domain 4 Linear Epitopes of the
Collar AL; Linville AC; Core SB; Wheeler CM; Geisler WM; Peabody DS; Chackerian B; Frietze KM
mSphere; 2020 Sep; 5(5):. PubMed ID: 32968007
[No Abstract] [Full Text] [Related]
15. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection.
Berry LJ; Hickey DK; Skelding KA; Bao S; Rendina AM; Hansbro PM; Gockel CM; Beagley KW
Infect Immun; 2004 Feb; 72(2):1019-28. PubMed ID: 14742549
[TBL] [Abstract][Full Text] [Related]
16.
Shillova N; Howe SE; Hyseni B; Ridgell D; Fisher DJ; Konjufca V
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33139380
[No Abstract] [Full Text] [Related]
17. Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.
Karunakaran KP; Yu H; Jiang X; Chan Q; Moon KM; Foster LJ; Brunham RC
Vaccine; 2015 Apr; 33(18):2159-66. PubMed ID: 25738816
[TBL] [Abstract][Full Text] [Related]
18. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
[TBL] [Abstract][Full Text] [Related]
19. Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis.
Frietze KM; Lijek R; Chackerian B
Expert Rev Vaccines; 2018 Nov; 17(11):959-966. PubMed ID: 30300019
[TBL] [Abstract][Full Text] [Related]
20. Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.
Yu H; Karunakaran KP; Jiang X; Brunham RC
Expert Rev Vaccines; 2016 Aug; 15(8):977-88. PubMed ID: 26938202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
